vs
B&G Foods, Inc.（BGS）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是B&G Foods, Inc.的1.4倍（$622.0M vs $439.3M），Royalty Pharma plc净利率更高（34.4% vs -4.4%，领先38.8%），Royalty Pharma plc同比增速更快（4.8% vs -4.7%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -12.8%）
B&G Foods是总部位于美国新泽西州帕西帕尼的品牌食品控股企业，创立于1996年，成立初衷是收购1889年诞生于曼哈顿的酸黄瓜、调味酱及调味品生产商Bloch & Guggenheimer，如今在北美食品领域拥有众多知名品牌。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
BGS vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.4倍
$439.3M
营收增速更快
RPRX
高出9.5%
-4.7%
净利率更高
RPRX
高出38.8%
-4.4%
两年增速更快
RPRX
近两年复合增速
-12.8%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $439.3M | $622.0M |
| 净利润 | $-19.1M | $214.2M |
| 毛利率 | 22.5% | — |
| 营业利润率 | 2.5% | 62.4% |
| 净利率 | -4.4% | 34.4% |
| 营收同比 | -4.7% | 4.8% |
| 净利润同比 | -356.5% | 2.9% |
| 每股收益（稀释后） | $-0.24 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BGSRPRX
| Q4 25 | — | $622.0M | ||
| Q3 25 | $439.3M | $609.3M | ||
| Q2 25 | $424.4M | $578.7M | ||
| Q1 25 | $425.4M | $568.2M | ||
| Q4 24 | $551.6M | $593.6M | ||
| Q3 24 | $461.1M | $564.7M | ||
| Q2 24 | $444.6M | $537.3M | ||
| Q1 24 | $475.2M | $568.0M |
净利润BGSRPRX
| Q4 25 | — | $214.2M | ||
| Q3 25 | $-19.1M | $288.2M | ||
| Q2 25 | $-9.8M | $30.2M | ||
| Q1 25 | $835.0K | $238.3M | ||
| Q4 24 | $-222.4M | $208.2M | ||
| Q3 24 | $7.5M | $544.0M | ||
| Q2 24 | $3.9M | $102.0M | ||
| Q1 24 | $-40.2M | $4.8M |
毛利率BGSRPRX
| Q4 25 | — | — | ||
| Q3 25 | 22.5% | — | ||
| Q2 25 | 20.5% | — | ||
| Q1 25 | 21.2% | — | ||
| Q4 24 | 21.5% | — | ||
| Q3 24 | 22.2% | — | ||
| Q2 24 | 20.7% | — | ||
| Q1 24 | 22.9% | — |
营业利润率BGSRPRX
| Q4 25 | — | 62.4% | ||
| Q3 25 | 2.5% | 70.1% | ||
| Q2 25 | 5.2% | 36.3% | ||
| Q1 25 | 8.4% | 94.0% | ||
| Q4 24 | -46.6% | 60.9% | ||
| Q3 24 | 11.1% | — | ||
| Q2 24 | 9.9% | 50.2% | ||
| Q1 24 | -3.3% | -13.0% |
净利率BGSRPRX
| Q4 25 | — | 34.4% | ||
| Q3 25 | -4.4% | 47.3% | ||
| Q2 25 | -2.3% | 5.2% | ||
| Q1 25 | 0.2% | 41.9% | ||
| Q4 24 | -40.3% | 35.1% | ||
| Q3 24 | 1.6% | 96.3% | ||
| Q2 24 | 0.9% | 19.0% | ||
| Q1 24 | -8.5% | 0.8% |
每股收益（稀释后）BGSRPRX
| Q4 25 | — | $0.49 | ||
| Q3 25 | $-0.24 | $0.67 | ||
| Q2 25 | $-0.12 | $0.07 | ||
| Q1 25 | $0.01 | $0.55 | ||
| Q4 24 | $-2.81 | $0.46 | ||
| Q3 24 | $0.09 | $1.21 | ||
| Q2 24 | $0.05 | $0.23 | ||
| Q1 24 | $-0.51 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $60.9M | $618.7M |
| 总债务越低越好 | $2.0B | $9.0B |
| 股东权益账面价值 | $470.7M | $9.7B |
| 总资产 | $2.9B | $19.6B |
| 负债/权益比越低杠杆越低 | 4.30× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资BGSRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | $60.9M | $938.9M | ||
| Q2 25 | $54.1M | $631.9M | ||
| Q1 25 | $61.2M | $1.1B | ||
| Q4 24 | $50.6M | $929.0M | ||
| Q3 24 | $54.7M | $950.1M | ||
| Q2 24 | $40.3M | $1.8B | ||
| Q1 24 | $42.5M | $843.0M |
总债务BGSRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | $2.0B | $8.9B | ||
| Q2 25 | $2.0B | $8.0B | ||
| Q1 25 | $2.0B | $7.6B | ||
| Q4 24 | $2.0B | $7.6B | ||
| Q3 24 | $2.1B | $7.6B | ||
| Q2 24 | $2.0B | $7.6B | ||
| Q1 24 | $2.0B | $6.1B |
股东权益BGSRPRX
| Q4 25 | — | $9.7B | ||
| Q3 25 | $470.7M | $9.6B | ||
| Q2 25 | $501.4M | $9.5B | ||
| Q1 25 | $513.1M | $9.8B | ||
| Q4 24 | $524.8M | $10.3B | ||
| Q3 24 | $755.3M | $10.3B | ||
| Q2 24 | $765.0M | $9.8B | ||
| Q1 24 | $781.2M | $9.9B |
总资产BGSRPRX
| Q4 25 | — | $19.6B | ||
| Q3 25 | $2.9B | $19.3B | ||
| Q2 25 | $2.9B | $18.3B | ||
| Q1 25 | $3.0B | $17.6B | ||
| Q4 24 | $3.0B | $18.2B | ||
| Q3 24 | $3.4B | $18.0B | ||
| Q2 24 | $3.4B | $17.7B | ||
| Q1 24 | $3.4B | $16.1B |
负债/权益比BGSRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | 4.30× | 0.93× | ||
| Q2 25 | 3.97× | 0.84× | ||
| Q1 25 | 3.91× | 0.78× | ||
| Q4 24 | 3.85× | 0.74× | ||
| Q3 24 | 2.75× | 0.74× | ||
| Q2 24 | 2.67× | 0.78× | ||
| Q1 24 | 2.61× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-64.6M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-70.7M | — |
| 自由现金流率自由现金流/营收 | -16.1% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $54.8M | — |
8季度趋势，按日历期对齐
经营现金流BGSRPRX
| Q4 25 | — | $827.1M | ||
| Q3 25 | $-64.6M | $702.6M | ||
| Q2 25 | $17.8M | $364.0M | ||
| Q1 25 | $52.7M | $596.1M | ||
| Q4 24 | $80.3M | $742.5M | ||
| Q3 24 | $4.2M | $703.6M | ||
| Q2 24 | $11.3M | $658.2M | ||
| Q1 24 | $35.1M | $664.6M |
自由现金流BGSRPRX
| Q4 25 | — | — | ||
| Q3 25 | $-70.7M | — | ||
| Q2 25 | $11.5M | — | ||
| Q1 25 | $42.4M | — | ||
| Q4 24 | $71.7M | — | ||
| Q3 24 | $-679.0K | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $27.5M | — |
自由现金流率BGSRPRX
| Q4 25 | — | — | ||
| Q3 25 | -16.1% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | 13.0% | — | ||
| Q3 24 | -0.1% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 5.8% | — |
资本支出强度BGSRPRX
| Q4 25 | — | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 1.6% | — |
现金转化率BGSRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | 63.17× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 0.56× | 1.29× | ||
| Q2 24 | 2.87× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BGS
| Specialty Segment | $150.5M | 34% |
| Meals Segment | $110.0M | 25% |
| Spices And Flavor Solutions Segment | $101.4M | 23% |
| Frozen And Vegetables Segment | $77.4M | 18% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
